Webinars and Sponsored Roundtables — Register Now

Tuesday, July 21, 2026, 11:00-11:30 AM CT

Learning Objectives:
  • Explain how transparency and manufacturer partnerships improve quality, consistency, and decision-making confidence in specimen management.
  • Evaluate blood collection tubes beyond cost and commodity assumptions, incorporating clinical impact and risk into decision-making.
  • Assess the potential risk points when using a blood collection device that has not been cleared for a specific purpose.

Roundtable presenters Nick Fingland, PhD, PMP, Senior Director, R&D Operations and Science, BD, and Chris Farnsworth, PhD, D(ABCC), Section Head of Clinical Chemistry, Professor of Pathology and Immunology, Washington University School of Medicine.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Wednesday, July 29, 2026, 1:00-2:00 PM ET
Learn about digital pathology technology that is future-ready, yet practical for today’s
laboratory needs.

Webinar presenters Scott Hammond, Senior Systems Consultant, Digital Pathology Division, Wexner Medical Center, Department of Pathology, and Ursula Hofer, Imaging Technologist, Pathology Digital Imaging Lab, Wexner Medical Center, Department of Pathology, and Sandra Banky, PA(ASCP), Director of Operations, Wexner Medical Center, Department of Pathology.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Subspecialties

Interactive Product Guides

Abstracts

Clinical pathology selected abstracts

June 2026—Platelet transfusion in neonate and pediatric patients prevents or stops bleeding. Platelet donor characteristics, such as sex and age, and further processing and storage of platelet units may impact platelet increments, overall transfusion burden, and clinical outcomes in pediatric and neonate transfusion recipients. Platelet collection and processing steps vary across blood centers.

Anatomic pathology selected abstracts

June 2026—Atypical endometriosis is a potential precursor of endometriosis-associated ovarian carcinoma. Despite this, identification of atypical endometriosis (AE) lacks established clinical implications and is not routinely incorporated in histopathological examinations for endometriosis. The authors conducted a study to determine the interobserver variability in AE diagnosis and classify features that may contribute to consistent identification and diagnosis.

Molecular pathology selected abstracts

June 2026—Studies of genetic variants in autism spectrum disorders have identified copy-number variants and single-nucleotide variants in more than 100 autism spectrum disorder-associated genes. However, much of the genetic and neurobiological bases of such disorders are still unclear. Some of the yet unexplained genetic basis of autism spectrum disorder (ASD) may lie in variants that may be difficult to detect by short-read whole genome sequencing (SR-WGS), such as specific structural variants and tandem repeats.

AI in cytology: where digital meets diagnostic

May 2026—Digital pathology has evolved substantially over the past decade. What started primarily as a platform for image storage now supports educational initiatives, remote signout, consultation, and image analysis deployment.

Anatomic pathology selected abstracts

May 2026—Use of AI to define spatial patterns of tumor-infiltrating lymphocytes associated with patient outcome; Expanding the clinicopathologic spectrum of EWSR1::SSX-rearranged sarcomas

Clinical pathology selected abstracts

April 2026—Circulating metabolites, genetics, and lifestyle factors in relation to future risk of type 2 diabetes; Clinical outcomes after COVID-19–positive donor heart transplantation in a pediatric population

Anatomic pathology selected abstracts

April 2026—CAR T-cell therapy-related gastrointestinal toxicity: histologic features and morphologic mimics; Clinicopathologic and genomic characterization of granuloma-rich hepatocellular carcinoma

Molecular pathology selected abstracts

April 2026—Use of long-read sequencing to monitor diagnostic blind spots of inherited metabolic diseases; Diffuse large B-cell lymphoma: a biologically heterogenous disease